跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Daivobet - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Daivobet
Approved
STANDARD
Daivobet
Leo Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7a9eb7c5b342feed
Company
Leo Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
7a9eb7c5b342feed
Drug Approval Philippines Name
Daivobet
Product Name
Daivobet
Registration Number
DR-XY28706
Brand Name
Daivobet
Generic Name
Calcipotriol (As Hydrate) + Betamethasone (As Dipropionate)
Dosage Form
50 mcg/500 mcg per gram
Dosage Strength
Calcipotriol (as hydrate) + Betamethasone (as dipropionate)
Manufacturer
Leo Laboratories Ltd.
Importer
ZUELLIG PHARMA CORPORATION
Distributor
ZUELLIG PHARMA CORPORATION
Company Detail Path
/organization/leo-laboratories-ltd
Issuance Date
15 June 2023
Expiry Date
12 June 2028
Pharmacologic Category
Antipsoriatic
Classification
Ointment
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7a9eb7c5b342feed
Type
Standard
Back to Philippines FDA Approvals